Professor,
$2 post
It makes no sense, He has this out 2016 [ Libi]
They need to raise capital. Was really nice man , give him a call yourself. He just EM me his report. I will read through it tonight. I asked if it was ok to post it....Waiting to see if he has a objection.
I did express my concerns with his evaluation. There is zero value PPS for their portfolio !
I pointed out the using the 70 cents pre split , is what has raised to question of how he arrived at $2.00
Graig mentioned Gvax was in Phase 1 clinical trials, I pointed out that those trial are in combo with other drug makers products... I continued to point out to him that there are in fact five late stage trails currently ongoing to Gvax...And that i believe a P3 just started for Gvax Panc....How can there be no value for these vaccines ??
Graig Suvannavejh PHD
212-284-2170
GL
